Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$748
|
$707B |
12.4x |
29.3x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$177
|
$459B |
5.0x |
13.6x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$218
|
$448B |
7.6x |
16.4x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 262
|
$288B |
3.7x |
9.4x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£118
|
$273B |
4.7x |
13.6x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 98
|
$262B |
4.7x |
11.6x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 348
|
$254B |
5.3x |
10.7x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$81
|
$229B |
3.5x |
7.9x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$474
|
$208B |
4.8x |
19.0x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$274
|
$196B |
5.6x |
10.6x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$184B |
2.9x |
7.5x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$113
|
$159B |
5.5x |
11.0x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$189
|
$149B |
6.1x |
19.5x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$46
|
$132B |
2.8x |
8.8x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€81
|
$123B |
2.3x |
7.9x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£15
|
$100B |
2.3x |
6.9x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$393
|
$96.0B |
8.2x |
23.4x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4493
|
$75.9B |
2.5x |
9.3x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 204
|
$74.2B |
4.7x |
14.0x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€28
|
$70.5B |
1.3x |
6.2x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$146
|
$70.2B |
7.4x |
17.1x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 6699
|
$67.8B |
8.2x |
16.3x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€107
|
$63.6B |
2.6x |
9.0x |
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 69
|
$59.5B |
13.3x |
45.2x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$461
|
$58.9B |
18.9x |
132.4x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$573
|
$55.9B |
4.0x |
11.4x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$54.2B |
3.6x |
14.4x |
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1040000
|
$53.2B |
13.6x |
31.2x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 547
|
$52.7B |
5.8x |
19.8x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$644
|
$52.6B |
12.7x |
36.9x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€207
|
$47.2B |
5.9x |
20.6x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 145
|
$45.2B |
9.0x |
39.3x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$186
|
$45.1B |
2.8x |
12.0x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€47
|
$44.2B |
1.7x |
10.2x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€644
|
$42.3B |
11.7x |
59.7x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3544
|
$41.9B |
3.1x |
14.8x |
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 106
|
$41.6B |
7.0x |
17.2x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1602
|
$40.9B |
6.6x |
23.2x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 65
|
$38.4B |
2.2x |
7.8x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$126
|
$37.5B |
5.5x |
19.1x |
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 212
|
$37.2B |
7.7x |
248.9x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 47
|
$29.5B |
2.6x |
12.7x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$143
|
$29.0B |
65.8x |
-29.5x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 8506
|
$28.9B |
1.8x |
7.6x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 170000
|
$28.8B |
9.9x |
29.6x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$275
|
$28.8B |
2.1x |
12.3x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1260
|
$28.1B |
7.1x |
22.6x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$181
|
$26.3B |
2.5x |
12.4x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$25.1B |
1.8x |
5.9x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$143
|
$24.8B |
2.6x |
7.7x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1691
|
$24.8B |
1.9x |
9.1x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$340
|
$24.2B |
9.8x |
42.0x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 36
|
$23.9B |
12.3x |
32.8x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$172
|
$22.8B |
11.5x |
-90.0x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$22.7B |
2.3x |
6.6x |
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€170
|
$21.9B |
6.4x |
21.7x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$35
|
$21.7B |
7.3x |
7.9x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 96
|
$20.1B |
12.6x |
148.4x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 354
|
$19.9B |
44.3x |
180.9x |
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 39
|
$19.2B |
6.7x |
18.9x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$299
|
$19.0B |
6.1x |
17.0x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 9
|
$18.9B |
4.3x |
16.5x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 491500
|
$18.7B |
119.5x |
207.4x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€11
|
$18.2B |
2.1x |
8.5x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6057
|
$17.8B |
15.8x |
49.1x |
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€64
|
$17.2B |
2.0x |
9.2x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 202
|
$17.0B |
11.0x |
33.1x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$101
|
$17.0B |
4.0x |
14.8x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$170
|
$16.4B |
2.0x |
10.1x |
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€115
|
$16.1B |
3.3x |
13.7x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€54
|
$15.4B |
5.2x |
13.7x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$403
|
$15.1B |
4.9x |
9.2x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 129
|
$14.9B |
34.9x |
-1933.7x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 509
|
$14.6B |
53.8x |
-375.0x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 31
|
$14.5B |
2.5x |
14.7x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1779
|
$14.4B |
4.1x |
10.9x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 11
|
$14.1B |
3.5x |
12.9x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$496
|
$14.0B |
6.0x |
27.4x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$83
|
$13.9B |
3.0x |
12.9x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3532
|
$13.8B |
10.0x |
30.5x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$19
|
$13.8B |
N/A |
-39.6x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$140
|
$13.4B |
5.0x |
21.2x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1548
|
$13.0B |
4.1x |
16.1x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$19
|
$12.9B |
2.8x |
14.7x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2583
|
$12.8B |
8.4x |
33.2x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 59
|
$12.8B |
2.2x |
15.6x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€167
|
$12.2B |
N/A |
N/A |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$84
|
$12.1B |
4.3x |
14.2x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1301
|
$12.1B |
3.2x |
12.4x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.9B |
0.3x |
5.4x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$53
|
$11.8B |
3.9x |
27.7x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2659
|
$11.7B |
3.7x |
9.3x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$125
|
$11.4B |
2.7x |
10.1x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1037
|
$11.3B |
4.1x |
14.4x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 270
|
$11.1B |
3.8x |
10.3x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€66
|
$11.1B |
5.6x |
17.8x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$11.0B |
1.7x |
5.6x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$51
|
$10.9B |
27.4x |
-23.8x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2047
|
$10.9B |
4.0x |
16.6x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€119
|
$10.9B |
2.6x |
7.1x |